Oral Immunization with F4 Fimbriae and CpG Formulated with Carboxymethyl Starch Enhances F4-Specific Mucosal Immune Response and Modulates Th1 and Th2 Cytokines in Weaned Pigs

Purpose. F4 fimbriae are a potential candidate for an oral subunit vaccine for prevention of post-weaning diarrhea in swine due to infection with F4-positive enterotoxigenic Escherichia coli. However, large quantities of F4 fimbriae are required to induce a specific antibody response. The aim of the...

Full description

Bibliographic Details
Main Authors: Benjamin Delisle, Carmen Calinescu, Mircea Alexandru Mateescu, John Morris Fairbrother, Eric Nadeau
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-12-01
Series:Journal of Pharmacy & Pharmaceutical Sciences
Online Access:https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/18159
_version_ 1797723395935174656
author Benjamin Delisle
Carmen Calinescu
Mircea Alexandru Mateescu
John Morris Fairbrother
Eric Nadeau
author_facet Benjamin Delisle
Carmen Calinescu
Mircea Alexandru Mateescu
John Morris Fairbrother
Eric Nadeau
author_sort Benjamin Delisle
collection DOAJ
description Purpose. F4 fimbriae are a potential candidate for an oral subunit vaccine for prevention of post-weaning diarrhea in swine due to infection with F4-positive enterotoxigenic Escherichia coli. However, large quantities of F4 fimbriae are required to induce a specific antibody response. The aim of the present study was to evaluate the effect of supplementation of F4 fimbriae with Cytosine-phosphate-Guanosine-oligodeoxynucleotide (CpG-A D19) or with complete cholera toxin (CT) as adjuvants on the F4-specific antibody response and cytokine production in weaned pigs following oral administration of F4 fimbrial antigen formulated with Carboxymethyl Starch (CMS). Methods. Oral dosage forms of F4 fimbriae alone or supplemented with CpG-A D19 or with CT were formulated with CMS as monolithic tablets, obtained by direct compression, and administered to weaned pigs. Blood and faecal samples were collected to determine the systemic and mucosal immune status of animals at various times until necropsy. During necropsy, contents of the jejunum and ileum were collected for determination of mucosal F4 specific antibodies. Segments of jejunum and ileum were also used to measure mRNA cytokine production. Results. The presence of CpG in the formulation of the fimbriae significantly increased F4-specific immunoglobulin (Ig) IgM and IgG levels in intestinal secretions, and enhanced Th1 (Interferon-gamma / IFN-γ, Tumour Necrosis Factor-alpha / TNF-α, Interleukin-12p40 / IL-12p40, IL-1β) and Th2 (IL-4, IL-6) cytokine production in intestinal tissues. Supplementation with CT did not result in induction of F4-specific antibodies in secretions, although a significant Th1 response (IFN-α, IFN-γ, IL-18) was detected in tissues. Neither F4-specific systemic antibodies, nor intestinally secreted IgA were detected throughout the immunization trial for all groups. Conclusions. CpG-A D19 appeared to be a promising adjuvant for an oral F4 subunit vaccine formulated with CMS excipient as monolithic tablets. This matrix afforded gastro-protection and delivered the F4 fimbriae at their intestinal sites. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
first_indexed 2024-03-12T10:01:17Z
format Article
id doaj.art-4b7af42a4eda482ea28037c27e81bfe7
institution Directory Open Access Journal
issn 1482-1826
language English
last_indexed 2024-03-12T10:01:17Z
publishDate 2012-12-01
publisher Frontiers Media S.A.
record_format Article
series Journal of Pharmacy & Pharmaceutical Sciences
spelling doaj.art-4b7af42a4eda482ea28037c27e81bfe72023-09-02T11:36:45ZengFrontiers Media S.A.Journal of Pharmacy & Pharmaceutical Sciences1482-18262012-12-0115510.18433/J30W32Oral Immunization with F4 Fimbriae and CpG Formulated with Carboxymethyl Starch Enhances F4-Specific Mucosal Immune Response and Modulates Th1 and Th2 Cytokines in Weaned PigsBenjamin Delisle0Carmen Calinescu1Mircea Alexandru Mateescu2John Morris Fairbrother3Eric Nadeau4Université de MontréalUniversité du Québec à MontréalUniversité du Québec à MontréalUniversité de MontréalUniversité de MontréalPurpose. F4 fimbriae are a potential candidate for an oral subunit vaccine for prevention of post-weaning diarrhea in swine due to infection with F4-positive enterotoxigenic Escherichia coli. However, large quantities of F4 fimbriae are required to induce a specific antibody response. The aim of the present study was to evaluate the effect of supplementation of F4 fimbriae with Cytosine-phosphate-Guanosine-oligodeoxynucleotide (CpG-A D19) or with complete cholera toxin (CT) as adjuvants on the F4-specific antibody response and cytokine production in weaned pigs following oral administration of F4 fimbrial antigen formulated with Carboxymethyl Starch (CMS). Methods. Oral dosage forms of F4 fimbriae alone or supplemented with CpG-A D19 or with CT were formulated with CMS as monolithic tablets, obtained by direct compression, and administered to weaned pigs. Blood and faecal samples were collected to determine the systemic and mucosal immune status of animals at various times until necropsy. During necropsy, contents of the jejunum and ileum were collected for determination of mucosal F4 specific antibodies. Segments of jejunum and ileum were also used to measure mRNA cytokine production. Results. The presence of CpG in the formulation of the fimbriae significantly increased F4-specific immunoglobulin (Ig) IgM and IgG levels in intestinal secretions, and enhanced Th1 (Interferon-gamma / IFN-γ, Tumour Necrosis Factor-alpha / TNF-α, Interleukin-12p40 / IL-12p40, IL-1β) and Th2 (IL-4, IL-6) cytokine production in intestinal tissues. Supplementation with CT did not result in induction of F4-specific antibodies in secretions, although a significant Th1 response (IFN-α, IFN-γ, IL-18) was detected in tissues. Neither F4-specific systemic antibodies, nor intestinally secreted IgA were detected throughout the immunization trial for all groups. Conclusions. CpG-A D19 appeared to be a promising adjuvant for an oral F4 subunit vaccine formulated with CMS excipient as monolithic tablets. This matrix afforded gastro-protection and delivered the F4 fimbriae at their intestinal sites. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/18159
spellingShingle Benjamin Delisle
Carmen Calinescu
Mircea Alexandru Mateescu
John Morris Fairbrother
Eric Nadeau
Oral Immunization with F4 Fimbriae and CpG Formulated with Carboxymethyl Starch Enhances F4-Specific Mucosal Immune Response and Modulates Th1 and Th2 Cytokines in Weaned Pigs
Journal of Pharmacy & Pharmaceutical Sciences
title Oral Immunization with F4 Fimbriae and CpG Formulated with Carboxymethyl Starch Enhances F4-Specific Mucosal Immune Response and Modulates Th1 and Th2 Cytokines in Weaned Pigs
title_full Oral Immunization with F4 Fimbriae and CpG Formulated with Carboxymethyl Starch Enhances F4-Specific Mucosal Immune Response and Modulates Th1 and Th2 Cytokines in Weaned Pigs
title_fullStr Oral Immunization with F4 Fimbriae and CpG Formulated with Carboxymethyl Starch Enhances F4-Specific Mucosal Immune Response and Modulates Th1 and Th2 Cytokines in Weaned Pigs
title_full_unstemmed Oral Immunization with F4 Fimbriae and CpG Formulated with Carboxymethyl Starch Enhances F4-Specific Mucosal Immune Response and Modulates Th1 and Th2 Cytokines in Weaned Pigs
title_short Oral Immunization with F4 Fimbriae and CpG Formulated with Carboxymethyl Starch Enhances F4-Specific Mucosal Immune Response and Modulates Th1 and Th2 Cytokines in Weaned Pigs
title_sort oral immunization with f4 fimbriae and cpg formulated with carboxymethyl starch enhances f4 specific mucosal immune response and modulates th1 and th2 cytokines in weaned pigs
url https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/18159
work_keys_str_mv AT benjamindelisle oralimmunizationwithf4fimbriaeandcpgformulatedwithcarboxymethylstarchenhancesf4specificmucosalimmuneresponseandmodulatesth1andth2cytokinesinweanedpigs
AT carmencalinescu oralimmunizationwithf4fimbriaeandcpgformulatedwithcarboxymethylstarchenhancesf4specificmucosalimmuneresponseandmodulatesth1andth2cytokinesinweanedpigs
AT mirceaalexandrumateescu oralimmunizationwithf4fimbriaeandcpgformulatedwithcarboxymethylstarchenhancesf4specificmucosalimmuneresponseandmodulatesth1andth2cytokinesinweanedpigs
AT johnmorrisfairbrother oralimmunizationwithf4fimbriaeandcpgformulatedwithcarboxymethylstarchenhancesf4specificmucosalimmuneresponseandmodulatesth1andth2cytokinesinweanedpigs
AT ericnadeau oralimmunizationwithf4fimbriaeandcpgformulatedwithcarboxymethylstarchenhancesf4specificmucosalimmuneresponseandmodulatesth1andth2cytokinesinweanedpigs